Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza ...

New York State’s stockpile of antiviral medications for flu contains only one drug, Tamiflu, leaving no fallback plan. By Joseph Goldstein A big boost for the military, more aid for Ukraine, a ...

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...

VANCOUVER, BC, Nov. 5, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

The Department of Health and Human Services (HHS) has canceled funding pledged to Moderna for the development of mRNA-based ...

The funding is through the Rapid Response Partnership Vehicle, a consortium funded by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority.

Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...

Morningstar brands and products Company Portfolio ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...